当前位置: X-MOL 学术JAMA Surg. › 论文详情
Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)
Should All Donors Be Treated by Ex Vivo Lung Perfusion?
JAMA Surgery ( IF 16.9 ) Pub Date : 2020-06-01 , DOI: 10.1001/jamasurg.2020.0043
Dong Tian 1, 2 , Yu Wang 3 , Shi-Yang Deng 1
Affiliation  

To the Editor We read with great interest the article by Divithotawela et al,1 which demonstrated the posttransplant long-term outcomes were similar between ex vivo lung perfusion (EVLP)–treated lung transplant (LTx) and standard LTx, although the quality of donor lungs was worse with EVLP-treated LTx. To our knowledge, this study is the largest study of EVLP and includes 230 EVLP cases. We congratulate Divithotawela et al1 for this excellent study.



中文翻译:

是否应该通过体内肺灌注治疗所有供体?

致编辑我们非常感兴趣地阅读了Divithotawela等人的文章,1证明了移植后的长期结果在离体肺灌注(EVLP)处理的肺移植(LTx)和标准LTx之间是相似的,尽管捐助者的质量EVLP处理的LTx使肺部状况恶化。据我们所知,该研究是最大的EVLP研究,包括230例EVLP病例。我们祝贺Divithotawela等1的出色研究。

更新日期:2020-06-01
down
wechat
bug